![Ren Ee Chee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Ren Ee Chee
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Rhapsody Biologics, Inc.
![]() Rhapsody Biologics, Inc. BiotechnologyHealth Technology Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA.
3
| Private Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ren Ee Chee
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
ALBANY MOLECULAR RESEARCH, INC. | Biotechnology | Director/Board Member | |
Coley Pharmaceutical Group, Inc.
![]() Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director of Finance/CFO | |
GELESIS INC | Biotechnology | Director/Board Member | |
Atlantic Healthcare Plc
![]() Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
FORMA Therapeutics, Inc.
![]() FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Operating Officer | |
MYREXIS, INC. | Financial Conglomerates | Director/Board Member | |
RENOVORX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ixcela, Inc.
![]() Ixcela, Inc. BiotechnologyHealth Technology Ixcela, Inc. operates in the healthcare industry focusing on biotechnology business. It develops diagnostic tests and natural interventions to improve gut microbiome efficacy and prevent neurodegenerative and cardiovascular diseases. The firm's technology is a proprietary biomarker discovery system integrating mass spectrometry and electrochemical arrays. The company was founded by Erika Ebbel Angle and Wayne R. Matson in 2012 and is headquartered in Bedford, MA. | Biotechnology | Chief Operating Officer | |
ViS Research, Inc.
![]() ViS Research, Inc. Data Processing ServicesTechnology Services ViS Research, Inc. provides an online feasibility platform for clinical trial planning. Its global site selection platform allows users to navigate sites by geographic location and disease-area expertise. The company was founded by Fabio Thiers in 2010 and is headquartered in New York, NY. | Data Processing Services | Chairman | |
MolecularWare, Inc.
![]() MolecularWare, Inc. Packaged SoftwareTechnology Services MolecularWare, Inc. develops data management software. It for high throughput biology, allowing scientists to manage and analyze data from high throughput instruments such as liquid handling robots, microarraying robots and microarray scanners. The company was founded by Seth Taylor in 1998 and is headquartered in Irvine, CA. | Packaged Software | Chief Executive Officer | |
American International College | College/University | Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal | |
Boston College | College/University | Graduate Degree | |
University of Bristol | College/University | Doctorate Degree Graduate Degree | |
The Angels' Forum Management Co LLC
![]() The Angels' Forum Management Co LLC Investment ManagersFinance The Angels' Forum Management Co LLC (The Angels' Forum) is a venture capital firm founded in 1997 by Carol Sands, Craig Sirnio and Alejandro Estrada. The firm is headquartered in Mountain View, California. | Investment Managers | Private Equity Investor | |
Whitehead Institute for Biomedical Research
![]() Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
New England Healthcare Institute
![]() New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Management Sciences for Health, Inc.
![]() Management Sciences for Health, Inc. Hospital/Nursing ManagementHealth Services Management Sciences for Health, Inc. provides healthcare services. The company was founded by Ronald O’Connor in 1971 and is headquartered in Medford, MA. | Hospital/Nursing Management | Director/Board Member | |
Net Daemons Associates, Inc. | Sales & Marketing | ||
MIT Enterprise Forum, Inc. | President | ||
The University of Law Ltd. | College/University | Graduate Degree | |
Bankinter Foundation of Innovation
![]() Bankinter Foundation of Innovation Investment ManagersFinance Bankinter Foundation of Innovation The report focuses on drawing conclusions about the potential socioeconomic impact of the trend discussed, particularly as it affects Spain, in order to communicate pragmatic, down-to-earth knowledge to our target audience. The company is headquartered in Madrid, Spain. | Investment Managers | Director/Board Member | |
VERASTEM, INC. | Biotechnology | Chief Executive Officer | |
Massachusetts Life Sciences Collaborative | Director/Board Member | ||
Diagnostics for All | Chief Executive Officer | ||
Washington University School of Medicine | College/University | Corporate Officer/Principal | |
The University of Miami Leonard M. Miller School of Medicine | College/University | Corporate Officer/Principal | |
The Bay Area Bioeconomy Initiative | Chairman | ||
SevenOaks Biosystems LLC
![]() SevenOaks Biosystems LLC Medical SpecialtiesHealth Technology Part of Medline Industries LP (Illinois), SevenOaks Biosystems LLC is a company that develops medical devices. The company is based in Cambridge, MA. The company was founded by Richard Rox Anderson, Sameer A. Sabir. SevenOaks Biosystems was acquired by Medline Industries LP (Illinois) on November 30, 2016. | Medical Specialties | Director/Board Member | |
Pillar Biosciences, Inc.
![]() Pillar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pillar Biosciences, Inc. is a clinical cancer diagnostics company. The firm engages in the creation of precision NGS panels and software solutions. It offers solid tumor panels, blood cancer panels, inherited disease panels, and custom panels. The company was founded by Gang Song and Zhaohui Wang in 2014 and is headquartered in Natick, MA. | Pharmaceuticals: Major | Director/Board Member | |
BC Platforms AG
![]() BC Platforms AG Data Processing ServicesTechnology Services BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland. | Data Processing Services | Chairman | |
Affyimmune Therapeutics, Inc.
![]() Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Deciduous Therapeutics, Inc.
![]() Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
EQRx International, Inc.
![]() EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
MIT Alumni Association
![]() MIT Alumni Association Miscellaneous Commercial ServicesCommercial Services The MIT Alumni Association operates as an alumni association for students. The private company is based in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Brixton Biosciences, Inc.
![]() Brixton Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Brixton Biosciences, Inc. has developed coolio™ therapy, an injection that provides long-lasting pain relief as an alternative to opioids. The company is based in Cambridge, MA and was founded by Robert M. Forrester and Sameer A. Sabir. The therapy is designed to desensitize pain in a targeted area and has the potential to eradicate the pain of pain. | Miscellaneous Commercial Services | Founder | |
OnCusp Therapeutics6
![]() OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then. | Miscellaneous Commercial Services | Director/Board Member | |
EQRX, INC. | Pharmaceuticals: Major | Founder | |
LOTTERY.COM INC. | Movies/Entertainment | Chairman | |
IDRx, Inc.
![]() IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
Eyecool Therapeutics, Inc.
![]() Eyecool Therapeutics, Inc. Medical SpecialtiesHealth Technology Eyecool Therapeutics, Inc. develops novel device-based technology for the treatment of dry eye. The company is based in Cambridge, MA. | Medical Specialties | Director/Board Member |
Statistik
International
Vereinigte Staaten | 43 |
Vereinigtes Königreich | 5 |
Kanada | 2 |
Spanien | 2 |
Schweiz | 2 |
Sektoral
Health Technology | 22 |
Commercial Services | 9 |
Consumer Services | 8 |
Finance | 6 |
Technology Services | 4 |
Operativ
Director/Board Member | 38 |
Corporate Officer/Principal | 14 |
Independent Dir/Board Member | 10 |
Chairman | 9 |
President | 7 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Una Ryan | 39 |
Robert M. Forrester | 25 |
Richard Paul Kivel | 17 |
- Börse
- Insiders
- Ren Ee Chee
- Unternehmensverbindungen